Optimer Pharmaceuticals, Inc. Cuts IPO Price To $8-$9

February 8, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Feb 8 (Reuters) - Optimer Pharmaceuticals Inc., a development stage company, on Thursday cut the expected price of its planned initial public offering to $8 to $9 per share from a previous range of $12 to $14.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

IPO